Interestingly, a combined mRNA vaccine containing both the HA antigen of IAV and the RBD of the SARS-CoV-2 S protein has shown pretty good immunogenicity and safety (128), which provides us with a new approach to develop vaccines against life-threatening infections. This evidence concerns the gene PROS1 and infection.